Medical Director, Clinical Development, Hepatology
GSK
Summary
A Medical Director, Clinical Development, Hepatology is sought to provide clinical and scientific insights to potential new, established and emerging assets in clinical development with a strong focus on liver diseases. You will work within project teams to plan, execute, and deliver clinical development activities up to and including registrational studies. You will report to the Clinical Development Lead.
Job description
Responsibilities
- Contribute to project team discussions on indication planning and incorporate input from across disciplines to support vital deliverables including the Target Product Profile (TPP), clinical development plan (CDP), study protocols, and integrated evidence strategy (IES) and planning.
- Provide effective support to the development and execution of the IES, including oversight of R&D evidence generation activities to ensure patient safety and study delivery.
- Design and execute clinical development plans across advanced stages of development, reflecting internal and external stakeholder input.
- Contribute to ambitious clinical development timelines by overseeing development of clinical study protocols, amendments, investigator brochures, clinical study reports etc.
- Input to, and may lead, regulatory interactions and documents including briefing documents, presentations, addressing questions and responses for assigned studies and programs.
- Provide medical monitoring and oversight of the safety of study participants on behalf of the Sponsor during the study, together with Pharmacovigilance Physician.
- If physician, accountability for Medical Governance across the project to ensure scientific integrity and overall safety of the study subjects across the study.
- Act as clinical lead for a clinical study, taking a key role on the Study Leadership Team (SLT) and serve as clinical point of contact for a clinical study on the Clinical Matrix Team (CMT).
- Make significant contributions to global regulatory submissions/files (e.g., IND, NDA, BLA, MAA), including briefing documents, presentations, and responses to regulatory questions.
- Evaluate specific business development activities, including due diligence and contributes to the implementation and embedding of strategic/organizational initiatives in Clinical Development.
- Stay abreast of advancements in therapeutic area research, clinical trial methodologies, competitive environment, and regulatory space.
Basic Qualifications
- Medical degree
- Clinical medical specialty training with board qualification/registration in Internal Medicine or Primary Care / Family Medicine.
- Completion of a full clinical residency program leading to board qualification or certification.
- Experience working in the pharmaceutical industry in clinical drug development, with understanding of clinical trial execution from concept to publication.
- Direct experience with in-stream medical oversight activities during trial conduct.
- Knowledge of ICH guidelines, FDA requirements, and global regulatory expectations.
- Understanding of clinical research methodology and biostatistical principles to support innovative and efficient clinical trial design and data-driven decision rules.
Preferred Qualifications
- Medical degree plus completion of advanced clinical specialty training with board qualification/registration in Hepatology (or equivalent higher specialty training).
- Familiarity or experience in MASH or ALD drug development, disease biology, therapeutic targets, and current/future treatment landscape.
- Clinical research experience in hepatology, including clinical development planning and interventional study design.
- Experience with site-facing interactions and/or activities supporting medical affairs, patient advocacy groups, or external organizations.
- Demonstrated ability to lead line or matrix teams, with a strong reputation for inspiring and motivating high performance.
- Experience engaging with regulators, payors, and prescribers in relevant markets.
- Experience integrating genetic data to inform clinical protocols.
- Proven ability to apply statistical and data visualization methods to interpret complex information, draw accurate conclusions, and support decision-making.
- Experience using new digital tools and learning technologies to drive innovation.
Requirements
- Medical degree
- Clinical medical specialty training with board qualification/registration in Internal Medicine or Primary Care / Family Medicine
- Completion of a full clinical residency program leading to board qualification or certification
- Experience working in the pharmaceutical industry in clinical drug development
- Understanding of clinical trial execution from concept to publication
- Direct experience with in-stream medical oversight activities during trial conduct
- Knowledge of ICH guidelines, FDA requirements, and global regulatory expectations
- Understanding of clinical research methodology and biostatistical principles
Benefits
- Health care
- Insurance benefits
- Retirement benefits
- Paid holidays
- Vacation
- Paid caregiver leave
- Paid parental leave
- Paid medical leave
- Annual bonus
- Share based long term incentive program
Company overview
GSK plc (formerly GlaxoSmithKline) is a British multinational pharmaceutical and biotechnology company headquartered in London, England. Founded in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham, GSK has grown to become one of the world's leading healthcare companies with operations in over 150 countries. The company specializes in researching, developing, and manufacturing prescription medicines, vaccines, and consumer healthcare products. GSK's therapeutic areas include respiratory diseases, HIV/AIDS, oncology, immunology, and infectious diseases. The company is particularly renowned for its vaccine portfolio and has been at the forefront of developing treatments for major global health challenges. With approximately 70,000 employees worldwide, GSK maintains a strong commitment to scientific innovation and has a significant presence in key markets including the United States, Europe, and emerging economies. The company's mission is to unite science, technology, and talent to get ahead of disease together, aiming to positively impact the health of 2.5 billion people by the end of the decade.